Block of cloned Kv4.3 potassium channels by dapoxetine. 2012

Imju Jeong, and Sae Woong Kim, and Shin Hee Yoon, and Sang June Hahn
Department of Physiology, Medical Research Center, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Socho-gu, Seoul 137-701, Republic of Korea.

Dapoxetine, a short-acting selective serotonin reuptake inhibitor, is widely prescribed for the treatment of patients with premature ejaculation. The effects of dapoxetine were examined on cloned Kv4.3 channels stably expressed in Chinese hamster ovary cells using the whole-cell patch-clamp technique. Dapoxetine not only reduced the peak amplitude of Kv4.3 currents but also accelerated the decay rate of current inactivation in a concentration-dependent manner. Thus, the concentration-dependent reduction in Kv4.3 was measured from the integral of the current during the depolarizing pulse. Dapoxetine decreased the integral of the Kv4.3 currents over the duration of a depolarizing pulse with an IC(50) of 5.3 μM. Analysis of the time dependence of the block gave estimates of an association rate constant (k(+1)) of 3.9 μM(-1)s(-1) and a dissociation rate constant (k(-1)) of 25.6s(-1). The K(D) (k(-1)/k(+1)) was 6.5 μM, similar to the IC(50) value calculated from the concentration-response curve. The block of Kv4.3 by dapoxetine was highly voltage-dependent at a membrane potential coinciding with the activation of the channels. The additional block by dapoxetine displayed a shallow voltage dependence (δ=0.21) in the full activation voltage range. The steady-state inactivation curves were shifted in the hyperpolarizing direction in the presence of dapoxetine. Dapoxetine also caused a substantial acceleration in closed-state inactivation. Dapoxetine produced a significant use-dependent block, which was accompanied by a delayed recovery from inactivation of Kv4.3 currents. These results indicated that dapoxetine potently blocks Kv4.3 currents by both preferentially binding to the open state of the channels and accelerating the closed-state inactivation. These data could provide insight into the mechanism underlying some of the therapeutic actions of this drug.

UI MeSH Term Description Entries
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D003412 Cricetulus A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters, Armenian,Hamsters, Chinese,Hamsters, Grey,Armenian Hamster,Armenian Hamsters,Chinese Hamster,Chinese Hamsters,Grey Hamster,Grey Hamsters,Hamster, Armenian,Hamster, Chinese,Hamster, Grey
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001596 Benzylamines Toluenes in which one hydrogen of the methyl group is substituted by an amino group. Permitted are any substituents on the benzene ring or the amino group. Phenylmethylamine,alpha-Aminotoluene,alpha Aminotoluene
D016466 CHO Cells CELL LINE derived from the ovary of the Chinese hamster, Cricetulus griseus (CRICETULUS). The species is a favorite for cytogenetic studies because of its small chromosome number. The cell line has provided model systems for the study of genetic alterations in cultured mammalian cells. CHO Cell,Cell, CHO,Cells, CHO
D051672 Shal Potassium Channels A shaker subfamily of potassium channels that participate in transient outward potassium currents by activating at subthreshold MEMBRANE POTENTIALS, inactivating rapidly, and recovering from inactivation quickly. KCND1 Potassium Channel,KCND2 Potassium Channel,KCND3 Potassium Channel,Kv4 Potassium Channels,Kv4.1 Potassium Channel,Kv4.2 Potassium Channel,Kv4.3 Potassium Channel,Kv4.3L Potassium Channel,Potassium Channel, KCND1,Potassium Channel, KCND2,Potassium Channel, KCND3,Potassium Channel, Kv4.1,Potassium Channel, Kv4.2,Potassium Channel, Kv4.3,Potassium Channel, Kv4.3L,Potassium Channels, Kv4,Potassium Channels, Shal
D026902 Potassium Channel Blockers A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS. Channel Blockers, Potassium,Potassium Channel Blocker,Blocker, Potassium Channel,Blockers, Potassium Channel,Channel Blocker, Potassium

Related Publications

Imju Jeong, and Sae Woong Kim, and Shin Hee Yoon, and Sang June Hahn
July 2012, Brain research,
Imju Jeong, and Sae Woong Kim, and Shin Hee Yoon, and Sang June Hahn
March 2013, Brain research,
Imju Jeong, and Sae Woong Kim, and Shin Hee Yoon, and Sang June Hahn
December 2011, The Journal of pharmacology and experimental therapeutics,
Imju Jeong, and Sae Woong Kim, and Shin Hee Yoon, and Sang June Hahn
August 2013, Naunyn-Schmiedeberg's archives of pharmacology,
Imju Jeong, and Sae Woong Kim, and Shin Hee Yoon, and Sang June Hahn
February 2013, Naunyn-Schmiedeberg's archives of pharmacology,
Imju Jeong, and Sae Woong Kim, and Shin Hee Yoon, and Sang June Hahn
June 2011, British journal of pharmacology,
Imju Jeong, and Sae Woong Kim, and Shin Hee Yoon, and Sang June Hahn
October 2014, European journal of pharmacology,
Imju Jeong, and Sae Woong Kim, and Shin Hee Yoon, and Sang June Hahn
August 2014, Neuroscience letters,
Imju Jeong, and Sae Woong Kim, and Shin Hee Yoon, and Sang June Hahn
July 2012, Naunyn-Schmiedeberg's archives of pharmacology,
Imju Jeong, and Sae Woong Kim, and Shin Hee Yoon, and Sang June Hahn
August 2015, Pflugers Archiv : European journal of physiology,
Copied contents to your clipboard!